Income Statement - AbCellera Biologics Inc. (ABCL)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 75.13 | 28.83 | 38.03 | 485.42 | 11.61 | 233.16 | 11.61 | 8.83 |
| Cost of revenue | 28.82 | 97.00 | 30.89 | 66.44 | 45.52 | 27.14 | 10.11 | 5.80 |
| Gross profit | 46.31 | 28.83 | 38.03 | 418.99 | 11.61 | 206.01 | 11.61 | 8.83 |
| Total operating expenses | 263.41 | 343.60 | 275.23 | 202.48 | 13.95 | 49.98 | 15.73 | 9.58 |
| Operating income | -217.10 | -314.77 | -237.21 | 216.51 | -4.12 | 156.03 | -4.12 | -0.75 |
| Non-operating income (net) | 39.51 | 114.37 | 63.18 | 22.59 | 1.91 | 1.80 | 1.91 | 1.06 |
| Income before tax | -177.60 | -200.40 | -174.03 | 239.10 | -2.21 | 157.83 | -2.21 | 0.31 |
| Income tax expense | -31.18 | -37.54 | -27.63 | 80.58 | 65.69 | 38.92 | 0.21 | 1.27 |
| Net income | -146.41 | -162.86 | -146.40 | 158.52 | -2.21 | 118.92 | -2.21 | 0.31 |
Show Quarterly Income Statement
Income Statement - AbCellera Biologics Inc. (ABCL)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.32 | 44.85 | 8.96 | 17.08 | 4.24 | 5.05 | 6.51 | 7.32 | 9.95 | 9.18 | 6.60 | 10.06 | 12.19 | 21.55 | 101.38 | 45.92 | 316.58 | 139.33 | 5.51 | 27.64 | 202.74 | 207.91 | 9.36 | 11.23 | 4.66 | 3.20 | 3.45 | 2.48 | 2.48 |
| Cost of revenue | 8.66 | 7.92 | 7.06 | 42.50 | 13.90 | 38.30 | 38.04 | 6.77 | 9.11 | 7.41 | 7.26 | 52.65 | 1.55 | 15.04 | 5.21 | 44.64 | 21.89 | 17.45 | 3.61 | 20.01 | 35.78 | 7.50 | 9.14 | 4.12 | 3.31 | 2.78 | 2.01 | 2.01 | |
| Gross profit | -0.34 | 36.93 | 8.96 | 17.08 | 4.24 | 5.05 | 6.51 | 7.32 | 9.95 | 9.18 | 6.60 | 10.06 | 12.19 | 19.99 | 86.35 | 40.71 | 271.94 | 117.44 | 5.51 | 24.03 | 182.73 | 207.91 | 9.36 | 11.23 | 4.66 | -0.11 | 0.67 | 0.47 | 0.47 |
| Total operating expenses | 57.18 | 65.52 | 85.23 | 66.67 | 66.90 | 77.81 | 100.17 | 100.78 | 64.85 | 75.23 | 61.49 | 61.45 | 77.07 | 57.77 | 48.61 | 49.10 | 46.99 | 35.88 | 33.60 | 31.07 | 24.66 | 47.13 | 11.13 | 12.08 | 6.78 | 5.18 | 0.63 | 0.77 | 0.77 |
| Operating income | -57.52 | -28.58 | -76.28 | -49.59 | -62.66 | -72.76 | -93.66 | -93.45 | -54.89 | -66.05 | -54.89 | -51.39 | -64.87 | -37.78 | 37.74 | -8.40 | 224.95 | 81.55 | -28.10 | -7.03 | 158.07 | 160.77 | -1.77 | -0.85 | -2.12 | -1.98 | -0.72 | -0.71 | -0.71 |
| Non-operating income (net) | 7.98 | 9.08 | 7.51 | 13.24 | 9.68 | 25.93 | 31.03 | 45.27 | 12.15 | 17.45 | 15.61 | 13.39 | 16.73 | 6.37 | 8.85 | 1.51 | 5.86 | 3.16 | 3.12 | 4.96 | 3.41 | -4.86 | -0.93 | 7.56 | 0.03 | 0.34 | 0.75 | 0.41 | 0.41 |
| Income before tax | -49.54 | -19.50 | -68.77 | -36.34 | -52.98 | -46.83 | -62.63 | -48.19 | -42.75 | -48.60 | -39.28 | -38.00 | -48.15 | -31.41 | 46.59 | -6.89 | 230.81 | 84.71 | -24.97 | -2.07 | 161.49 | 155.91 | -2.69 | 6.70 | -2.09 | -1.64 | 0.04 | -0.30 | -0.30 |
| Income tax expense | -6.37 | -10.55 | -11.65 | -1.62 | -7.36 | -12.62 | -11.53 | -11.26 | -2.14 | -1.45 | -10.67 | -7.48 | -8.04 | -1.52 | 19.96 | -0.10 | 62.24 | 24.76 | -3.59 | 0.25 | 44.27 | 38.92 | 0.00 | 0.08 | |||||
| Net income | -43.17 | -8.95 | -57.12 | -34.73 | -45.62 | -34.21 | -51.11 | -36.93 | -40.61 | -47.15 | -28.61 | -30.53 | -40.11 | -29.89 | 26.62 | -6.79 | 168.57 | 59.95 | -21.38 | -2.32 | 117.22 | 117.00 | -2.69 | 6.70 | -2.09 | -1.64 | 0.04 | -0.30 | -0.30 |